You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • FRI0380 An indirect comparisons analysis of prostacyclins, endothelin receptor antagonists and phosphodiesterase inhibitors to evaluate for differences between the treatment for primary and secondary pulmonary hypertension

Article metrics

Article menu
Download PDFPDF
Poster Presentation
Scleroderma, myositis and related syndromes
FRI0380 An indirect comparisons analysis of prostacyclins, endothelin receptor antagonists and phosphodiesterase inhibitors to evaluate for differences between the treatment for primary and secondary pulmonary hypertension

 

Online download statistics by month:

Online download statistics by month: February 2014 to December 2023

AbstractFullPdf
Feb 2014203
Mar 2014500
Apr 2014100
May 2014300
Sep 2014202
Oct 2014401
Nov 2014401
Feb 2015802
Mar 2015301
Apr 2015201
May 2015200
Jun 2015100
Jul 2015100
Aug 2015100
Sep 2015300
Nov 2015102
Feb 2016300
Apr 2016100
May 2016401
Jun 2016100
Jul 2016600
Aug 2016300
Sep 2016401
Oct 201623069
Nov 2016300
Dec 2016500
Jan 2017500
Feb 2017100
Mar 2017900
Apr 2017400
May 2017600
Jun 2017900
Jul 2017600
Aug 20172200
Sep 20171200
Oct 20172200
Nov 20172200
Dec 20172800
Jan 20181400
Feb 20181200
Mar 20181800
Apr 2018800
May 20182001
Jun 2018600
Jul 2018600
Aug 2018800
Sep 2018600
Oct 2018801
Nov 2018200
Dec 2018200
Feb 2019200
Apr 2019200
May 2019200
Jun 2019100
Aug 2019201
Nov 2019200
Jan 2020200
Feb 2020200
May 2020801
Jul 2020200
Sep 2020800
Oct 2020200
Nov 2020300
Dec 2020400
Jan 2021200
Mar 2021300
Apr 2021500
Sep 2021001
Nov 2021500
Dec 20211200
Jan 2022900
Feb 2022600
Apr 2022200
May 2022200
Jul 20221000
Aug 20221000
Sep 2022400
Oct 2022200
Nov 20221200
Dec 2022400
Jan 2023800
Feb 2023800
Mar 20231200
Apr 2023801
May 2023600
Jun 2023400
Jul 2023200
Sep 2023800
Oct 2023400
Nov 2023200
Dec 20231200
Total556090